Product Description: Anti-osteoporosis agent-8 (Compound 4aa) is an inhibitor for RANKL, which inhibits RANKL-induced osteoclastogenesis and osteoclast differentiation (IC50 is 2.41 μM) in cells RAW264.7. Anti-osteoporosis agent-8 ameliorates bone loss in an ovariectomized (OVX) mice model[1].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C18H19F3N2O2Se
References: [1]Wu Y, et al., Design, Synthesis, and Biological Evaluation of β-Trifluoroethoxydimethyl Selenides as Potent Antiosteoporosis Agents. J Med Chem. 2024 May 9;67(9):7585-7602.
Molecular Weight: 431.31
Research Area: Endocrinology
Solubility: 10 mM in DMSO
Target: NF-κB;p38 MAPK;RANKL/RANK